Fate Therapeutics Inc. (FATE) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Fate Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Fate Therapeutics Inc. (FATE) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $248M. It trades at $2.17, up 4.83% today. Its overall quality score is 33 out of 100, ranked against the whole US market. 3 analysts' average target of $6.63 implies +205.5% from today's price. Kronos AI's 30-day forecast is +9.7% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $6.63 |
| Low – high | $3.50 – $8.00 |
| Analysts | 3 |
| Upside to average | +205.5% |
Kronos AI 30-day forecast
| Expected close | $2.27 (+9.7%) |
| Likely range | +5.8% … +34.0% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 8 |
| Solvency | 48 |
| Growth | 43 |
| Overall | 33 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator